Short Interest in Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Declines By 90.3%

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 1,089 shares, a drop of 90.3% from the August 15th total of 11,255 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 12,371 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Stock Performance

Shares of Cuprina Holdings (Cayman) stock traded up $0.09 during trading hours on Thursday, hitting $3.00. 8,524 shares of the company’s stock traded hands, compared to its average volume of 44,311. Cuprina Holdings has a 12-month low of $1.76 and a 12-month high of $14.80. The company has a fifty day simple moving average of $3.48 and a 200-day simple moving average of $3.21. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.